Amgen acquiring BioVex for $425 million up front and $575 million in milestones

BioVex Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Amgen Inc.

U.S. / Large-Cap Biopharma (>=$50 billion)

$53,826.1m on 01/21/2011 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed